Edition:
United Kingdom

Santen Pharmaceutical Co Ltd (4536.T)

4536.T on Tokyo Stock Exchange

1,908JPY
15 Dec 2017
Change (% chg)

-- (--)
Prev Close
¥1,908
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,236,636
52-wk High
¥1,941
52-wk Low
¥1,343

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep 54,826.00 15.300
Jun 55,948.00 22.116
FY 2017 Mar '17 48,429.00 7.966
Dec 52,838.00 17.640
Sep 47,823.00 12.478
Jun 50,006.00 17.613
FY 2016 Mar '16 46,087.00 8.384
Dec 51,331.00 14.986
Sep 49,898.00 86.897
Jun 47,975.00 18.152
FY 2015 Mar '15 45,029.00 16.298
Dec 44,882.00 18.083
Sep 38,233.00 13.665
Jun 33,687.00 9.810
 
*Note: Units in Millions ofYen
**Note: Units in Yen

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-17 2 51,473.00 51,633.00 51,313.00 --
Quarter Ending Jun-18 1 55,000.00 55,000.00 55,000.00 --
Year Ending Mar-17 10 200,918.00 202,300.00 196,600.00 --
Year Ending Mar-18 10 219,331.00 225,310.00 206,000.00 210,111.00
Year Ending Mar-19 10 228,096.00 237,757.00 212,000.00 219,057.00
Earnings (per share)
Quarter Ending Mar-17 2 13.93 15.94 11.91 --
Quarter Ending Jun-18 1 21.17 21.17 21.17 --
Year Ending Mar-17 11 66.00 78.54 59.10 --
Year Ending Mar-18 11 70.77 80.42 65.50 69.79
Year Ending Mar-19 11 75.58 87.16 60.60 77.80
LT Growth Rate (%) 2 11.29 15.48 7.10 -12.35
Sales and Profit Figures in Japanese Yen (JPY);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 28.99 31.14 32.93
P/E High - Last 5 Yrs. 30.21 40.91 45.62
P/E Low - Last 5 Yrs. 13.18 23.80 24.34
Beta 0.58 0.90 0.88
Price to Sales (TTM) 3.46 3.93 5.40
Price to Book (MRQ) 2.73 4.81 5.38
Price to Tangible Book (MRQ) 4.49 5.53 6.78
Price to Cash Flow (TTM) 20.38 23.04 23.45
% Owned Institutions -- 0.88 1.40

Dividends

  Company industry sector
Dividend Yield 1.49 1.56 1.50
Dividend Yield - 5 Year Avg 1.65 1.57 1.52
Dividend 5 Year Growth Rate 5.39 4.33 5.17
Payout Ratio(TTM) 43.17 45.73 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 11.88 3.57 9.00
Sales (TTM) vs TTM 1 Yr. Ago 3.91 4.66 5.38
Sales - 5 Yr. Growth Rate 11.72 10.11 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 24.23 16.54 19.67
EPS (TTM) vs TTM 1 Yr. Ago -52.93 -- --
EPS - 5 Yr. Growth Rate 7.31 9.86 10.79
Capital Spending - 5 Yr. Growth Rate 23.70 15.30 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 2.62 2.11 2.18
Current Ratio (MRQ) 3.16 2.88 2.98
LT Debt to Equity (MRQ) 2.37 9.47 11.56
Total Debt to Equity (MRQ) 8.05 13.43 15.81
Interest Coverage (TTM) 47.31 36.29 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 61.88 55.14 54.83
Gross Margin - 5 Yr. Avg. 63.12 52.29 52.40
EBITD Margin (TTM) 21.40 -- --
EBITD - 5 Yr. Avg 28.55 18.46 15.24
Operating Margin (TTM) 16.45 14.50 7.76
Operating Margin - 5 Yr. Avg. 24.66 14.42 10.75
Pre-Tax Margin (TTM) 16.47 14.95 8.57
Pre-Tax Margin - 5 Yr. Avg. 24.72 14.74 11.17
Net Profit Margin (TTM) 12.02 11.22 4.88
Net Profit Margin - 5 Yr. Avg. 16.64 11.08 7.47
Effective Tax Rate (TTM) 27.04 23.21 23.11
Effective Tax Rate - 5 Yr. Avg. 32.70 23.44 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 55,914,640 953,213,828 864,680,848
Net Income/Employee (TTM) 6,721,026 112,151,383 101,718,394
Receivable Turnover (TTM) 2.81 5.60 5.76
Inventory Turnover (TTM) 2.98 2.58 3.34
Asset Turnover (TTM) 0.63 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 7.53 11.42 11.00
Return on Assets - 5 Yr. Avg. 10.07 13.00 12.43
Return on Investment (TTM) 8.89 14.86 14.46
Return on Investment - 5 Yr. Avg. 12.19 17.00 16.28
Return on Equity (TTM) 9.56 16.28 16.05
Return on Equity - 5 Yr. Avg. 13.23 18.03 17.51
  1 Year 3 Year 5 Year
Sales % 1.95 10.83 11.72
EPS (TTM) % -56.40 5.54 7.31
Dividend % 4.00 9.14 5.39
Note: Units in Millions of US Dollars

Performance for Santen Pharmaceutical Co Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -2.24 -7.67 99 25
13 Week 13.02 7.65 99 37
26 Week 15.03 1.57 99 30
52 Week 14.80 -7.87 99 12
YTD 22.03 9.84 99 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 45.69%
# of Holders: 239
Total Shares Held: 185,664,285
3 Mo. Net Change: 4,329,502
# New Positions: 5
# Closed Positions: 3
# Increased Positions: 66
# Reduced Positions: 45
# Net Buyers: 21
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.